Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2009 1
2011 1
2012 1
2013 1
2014 1
2018 3
2019 9
2020 8
2021 13
2022 10
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Systemic therapy in cervical cancer: 30 years in review.
Liontos M, Kyriazoglou A, Dimitriadis I, Dimopoulos MA, Bamias A. Liontos M, et al. Among authors: kyriazoglou a. Crit Rev Oncol Hematol. 2019 May;137:9-17. doi: 10.1016/j.critrevonc.2019.02.009. Epub 2019 Feb 28. Crit Rev Oncol Hematol. 2019. PMID: 31014518 Review.
Clear cell sarcoma: state-of-the art and perspectives.
Wetterwald L, Riggi N, Kyriazoglou A, Dei Tos G, Dei Tos A, Digklia A. Wetterwald L, et al. Among authors: kyriazoglou a. Expert Rev Anticancer Ther. 2023 Mar;23(3):235-242. doi: 10.1080/14737140.2023.2183846. Epub 2023 Feb 27. Expert Rev Anticancer Ther. 2023. PMID: 36811446 Review.
Cutaneous soft tissue sarcomas: survival-related factors.
Gkantaifi A, Diamantis A, Mauri D, Nixon I, Kyriazoglou A, Baloyiannis I, Tsoukalas N, Charalampakis N, Schizas D, Cuccia F, Alongi F, de Mello RA, Iliadis G, Kamposioras K, Mazonakis M, Tolia M. Gkantaifi A, et al. Among authors: kyriazoglou a. Arch Dermatol Res. 2022 Sep;314(7):625-631. doi: 10.1007/s00403-021-02268-1. Epub 2021 Jul 17. Arch Dermatol Res. 2022. PMID: 34272971 Review.
Tyrosine kinase inhibitors in sarcoma treatment.
Kyriazoglou A, Gkaralea LE, Kotsantis I, Anastasiou M, Pantazopoulos A, Prevezanou M, Chatzidakis I, Kavourakis G, Economopoulou P, Nixon IF, Psyrri A. Kyriazoglou A, et al. Oncol Lett. 2022 Jun;23(6):183. doi: 10.3892/ol.2022.13303. Epub 2022 Apr 21. Oncol Lett. 2022. PMID: 35527786 Free PMC article. Review.
Immune checkpoint inhibitors in sarcomas: a systematic review.
Anastasiou M, Kyriazoglou A, Kotsantis I, Economopoulou P, Kyrkasiadou M, Giannopoulou A, Kosmidou A, Smerdi D, Moutafi M, Gavrielatou N, Psyrri A. Anastasiou M, et al. Among authors: kyriazoglou a. Immunooncol Technol. 2023 Sep 28;20:100407. doi: 10.1016/j.iotech.2023.100407. eCollection 2023 Dec. Immunooncol Technol. 2023. PMID: 38192615 Free PMC article. Review.
Systematic Review of Recurrent Osteosarcoma Systemic Therapy.
Gazouli I, Kyriazoglou A, Kotsantis I, Anastasiou M, Pantazopoulos A, Prevezanou M, Chatzidakis I, Kavourakis G, Economopoulou P, Kontogeorgakos V, Papagelopoulos P, Psyrri A. Gazouli I, et al. Among authors: kyriazoglou a. Cancers (Basel). 2021 Apr 7;13(8):1757. doi: 10.3390/cancers13081757. Cancers (Basel). 2021. PMID: 33917001 Free PMC article. Review.
Superficial soft tissue sarcomas: 10‑year survival outcomes.
Tolia M, Gkantaifi A, Hayward L, Gupta G, Kyriazoglou A, Mauri D, Nixon I. Tolia M, et al. Among authors: kyriazoglou a. Oncol Lett. 2023 Jan 27;25(3):96. doi: 10.3892/ol.2023.13682. eCollection 2023 Mar. Oncol Lett. 2023. PMID: 36817037 Free PMC article.
Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC).
Economopoulou P, Spathis A, Kotsantis I, Maratou E, Anastasiou M, Moutafi MK, Kirkasiadou M, Pantazopoulos A, Giannakakou M, Edelstein DL, Sloane H, Fredebohm J, Jones FS, Kyriazoglou A, Gavrielatou N, Foukas P, Panayiotides I, Psyrri A. Economopoulou P, et al. Among authors: kyriazoglou a. Oral Oncol. 2023 Apr;139:106358. doi: 10.1016/j.oraloncology.2023.106358. Epub 2023 Mar 3. Oral Oncol. 2023. PMID: 36871349
49 results